Effect of Laparoscopic Splenectomy on Renal Function in Cirrhotic Patients With Hypersplenism (2-Year Follow-Up)
- Sponsor
- Northern Jiangsu People's Hospital
- Study ID
- NCT07585773
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Cirrhosis
- Hypersplenism
- Kidney Function Issue
- Splenectomy; Status
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 80 Years
- Healthy Volunteers
- Not accepted
Study Details
Patients with liver cirrhosis often have impaired or at-risk kidney function due to the close link between liver and kidney (hepatorenal syndrome). Laparoscopic splenectomy is commonly used to treat splenomegaly and hypersplenism in these patients, but its impact on kidney function over 2 years is unclear. This study will follow patients undergoing laparoscopic splenectomy to measure changes in kidney function before and after surgery, identify risk factors for kidney damage and whether laparoscopic splenectomy can improve kidney function in the long term, and help improve care to protect kidney function in cirrhotic patients .
Key Dates
- First listed
- May 14, 2026
- Start date
- May 1, 2026
- Status verified
- May 2026
- Primary completion
- Feb 28, 2029
- Completion
- Feb 28, 2029
Study Design
- Enrollment
- 30 participants (estimated)
Primary Outcome Measure
Serum creatinine (Scr) level [ Time Frame: at preoperative baseline, postoperative month 1, month 3, month 6, month 12, month 18, month 24 ]
Central Contacts
- Guo-Qing Jiang, MD+8651487373272
- Dou-Sheng Bai, MD+8651487373372
Related Studies
- Blood Collection Biorepository for Liver Disease ResearchRecruiting · State University of New York at Buffalo · Buffalo, New York
- Mechanisms of Malnutrition in Cirrhosis With Portosystemic ShuntingRecruiting · The Cleveland Clinic · Cleveland, Ohio
- Novel Tracer Methods to Evaluate Muscle Protein Metabolism in CirrhosisRecruiting · The Cleveland Clinic · Cleveland, Ohio
- Safety and Efficacy of Atorvastatin v. Placebo on HCC RiskPHASE2 · Recruiting · Raymond Chung · Boston, Massachusetts